QCORE Stock Overview
Provides visualization-based bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Qlucore AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 5.30 |
| 52 Week High | SEK 11.50 |
| 52 Week Low | SEK 5.05 |
| Beta | 0.39 |
| 1 Month Change | -4.50% |
| 3 Month Change | -23.19% |
| 1 Year Change | -13.11% |
| 3 Year Change | -87.53% |
| 5 Year Change | n/a |
| Change since IPO | -90.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| QCORE | SE Healthcare Services | SE Market | |
|---|---|---|---|
| 7D | -6.2% | -4.6% | -0.9% |
| 1Y | -13.1% | 85.2% | 8.9% |
Return vs Industry: QCORE underperformed the Swedish Healthcare Services industry which returned 85.2% over the past year.
Return vs Market: QCORE underperformed the Swedish Market which returned 8.9% over the past year.
Price Volatility
| QCORE volatility | |
|---|---|
| QCORE Average Weekly Movement | 7.3% |
| Healthcare Services Industry Average Movement | 6.1% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in SE Market | 11.4% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: QCORE has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: QCORE's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 21 | Carl-Johan Ivarsson | www.qlucore.com |
Qlucore AB (publ) provides visualization-based bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. Its products include Qlucore Omics Explorer, a bioinformatics software for research in life science, biotech, and plant industries, as well as academia; Qlucore Insights, a software for clinical data analysis; and Qlucore Diagnostics, a software platform for multi-omics companion. The company was incorporated in 2007 and is headquartered in Lund, Sweden.
Qlucore AB (publ) Fundamentals Summary
| QCORE fundamental statistics | |
|---|---|
| Market cap | SEK 21.15m |
| Earnings (TTM) | -SEK 20.91m |
| Revenue (TTM) | SEK 26.00m |
0.8x
P/S Ratio-1.0x
P/E RatioIs QCORE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QCORE income statement (TTM) | |
|---|---|
| Revenue | SEK 26.00m |
| Cost of Revenue | SEK 28.57m |
| Gross Profit | -SEK 2.57m |
| Other Expenses | SEK 18.33m |
| Earnings | -SEK 20.91m |
Last Reported Earnings
Oct 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.19 |
| Gross Margin | -9.90% |
| Net Profit Margin | -80.42% |
| Debt/Equity Ratio | 3.7% |
How did QCORE perform over the long term?
See historical performance and comparison